Transplantation

Approval Granted for Ceprate SC Stem Cell Concentration System

Published in Blood Weekly, December 23rd, 1996

CellPro Inc., Bothell, Washington, announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for the Ceprate SC Stem Cell Concentration System.

The Ceprate SC System is indicated for purification of stem cells for bone-marrow transplantation. The Ceprate SC System is the first cell processing system approved by the FDA for this indication.

"Receipt of marketing approval and the U.S. launch of the Ceprate SC System are pivotal corporate accomplishments for CellPro that will help propel the development of future cell therapy products based on our core cell selection technology," said Richard Murdock, CellPro. "These...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1996-12-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry